Biotherapeutics Cell Line Development Market Biotherapeutics Cell Line Development Market : ToC


Biotherapeutics Cell Line Development Market

Biotherapeutics Cell Line Development Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022

  • Rep Id : TMRGL8272
  • Published On : Dec 2015
  • No. of Pages : 104
  • Category : Healthcare


Chapter 1  Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Biotherapeutics Cell Line Development Market
2.2 Comparative Analysis: Global Biotherapeutics Cell Line Development Market, by Geography, 2014 & 2022

Chapter 3 Biotherapeutics Cell Line Development Market Overview
3.1 Introduction
3.2 Market Dynamics
       3.2.1 Drivers
       3.2.2 Restraints
       3.2.3 Opportunities
3.3 Biotherapeutics Cell Line Development Sites: Qualitative Analysis, 2014
3.4 Market Attractiveness Analysis: Biotherapeutics Cell Line Development Market, by Geography, 2014
3.5 Competitive Landscape: FACS Market
       3.5.1 Market Share by Revenue, by Key Players, 2014 (Value %)

Chapter 4 Global Biotherapeutics Cell Line Development Market Revenue, by Process, 2014 – 2022 (USD Million)
4.1 Introduction
4.2 Transfection & Selection
4.3 Single Cell Cloning
       4.3.1 Manual Limited Dilution Cloning (e.g. Single Cell Imagers such as CloneSelect, etc.)
       4.3.2 FACS
       4.3.3 ClonePix

Chapter 5 Global Biotherapeutics Cell Line Development Market Revenue, by CLD Option, 2014 – 2022 (USD Million)
5.1 Introduction
5.2 In-house
5.3 Outsource
5.4 Do-it-yourself (DIY)
5.5 Hybrid

Chapter 6 Global Biotherapeutics Cell Line Development Market Revenue, by Geography, 2014 – 2022 (USD Million)
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East & Africa (MEA)

Chapter 7 Recommendations
7.1 Past and Future Trends
7.2 Barriers to success

Chapter 8 Company Profiles
8.1 Becton, Dickinson and Company
       8.1.1 Company Overview
       8.1.2 Financial Overview
       8.1.3 Product Portfolio
       8.1.4 Business Strategies
       8.1.5 Recent Developments
8.2 Beckman Coulter, Inc. (Danaher Corporation)
8.3 Boehringer Ingelheim Pharma GmbH & Co KG.
8.4 Catalent, Inc.
8.5 CMC Biologics
8.6 Lonza Group Ltd.
8.7 Partec (Sysmex Corporation)
8.8 ProBioGen AG
8.9 SAFC (Sigma-Aldrich Corporation)
8.10 Selexis SA
8.11 Sony Biotechnology Inc. (Sony Corporation)
8.12 Thermo Fisher Scientific, Inc.
8.13 Others

.